Trial intelligence / Profile preview

Prednisolone Intranasal Film for Post-COVID Anosmia

NCT05328414Phase 2Completed

Sponsor
Deraya University
Start
Mar 2022
Primary completion
Mar 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of prednisolone in anosmia and Hyposmia, sponsored by Deraya University. Primary endpoint: Smell restoring at 3 weeks. Started Mar 2022; status: completed.

02

Drugs

prednisolone
03

Conditions

anosmiaHyposmia

Beyond the preview

Go deeper on NCT05328414.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05328414.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call